DAIC

FEBRUARY 14, 2024

Given this dismal outcome, the prognosis of CLTI is worse than most cancers.3,4 The global burden of peripheral artery disease. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Heart Assoc. J Vasc Surg. 2023;77:1119-26.

Heart Attack 111

Heart Attack Heart attacks Peripheral Arterial Disease Ischemia 111

Heart BMJ

MARCH 12, 2024

Eligible and ineligible patients were compared on baseline characteristics, cardiovascular events, major bleeding and mortality.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease Myocardial Infarction 40

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Science Daily - Heart Disease

FEBRUARY 16, 2024

Having a heart attack significantly increases the risk of developing other serious long-term health conditions, a major new study shows. Up to a third of patients went on to develop heart or kidney failure, 7% had further heart attacks and 38% died from any cause within the nine-year study period.

Heart Attack 44

Heart Attack Heart attacks Peripheral Arterial Disease Atrial Fibrillation 44

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Heart BMJ

MARCH 12, 2024

The study aims to evaluate the applicability in the real world of randomised clinical trials (RCT) on antithrombotic treatment in patients with cardiovascular disease (CVD) and peripheral artery disease (PAD).

Peripheral Arterial Disease 52

Peripheral Arterial Disease Myocardial Infarction Heart Attack Heart attacks 52

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105